Early clinical evaluation in man: the buck stops here

Area of Science:

• Pharmacology
• Clinical Medicine
• Drug Development

Background:

• New drug development is a complex, team-based endeavor.
• Clinicians must navigate scientific and ethical considerations, prioritizing patient safety ('Primum non nocere').

Purpose of the Study:

• To highlight the critical and unique responsibilities of clinical pharmacologists in the drug development process.
• To emphasize the need for thorough evaluation of pharmacologic actions, antidotes, and animal data translation.

Main Methods:

• Review of the roles and responsibilities within multidisciplinary drug development teams.
• Analysis of key considerations for clinical pharmacologists, including ethical issues, pharmacologic assessment, and animal data interpretation.

Main Results:

• Clinical pharmacologists are essential for assessing drug safety and efficacy.
• Evaluating species differences in pharmacologic actions and drug metabolism is crucial for correlating animal data with human outcomes.
• Ensuring the welfare of human subjects is a primary responsibility.

Conclusions:

• The clinical pharmacologist's role is integral to safe and effective new drug development.
• A comprehensive understanding of drug actions, metabolism, and potential toxicities, informed by animal studies, is vital.
• Protecting volunteer and patient welfare is a non-negotiable ethical imperative.